235 related articles for article (PubMed ID: 17487803)
1. Antibiotic prophylaxis in cerebrospinal fluid shunting: reassessment of Cefotiam penetration into human CSF.
Knoop M; Schütze M; Piek J; Drewelow B; Mundkowski R
Zentralbl Neurochir; 2007 Feb; 68(1):14-8. PubMed ID: 17487803
[TBL] [Abstract][Full Text] [Related]
2. Characteristics and treatment outcome of cerebrospinal fluid shunt-associated infections in adults: a retrospective analysis over an 11-year period.
Conen A; Walti LN; Merlo A; Fluckiger U; Battegay M; Trampuz A
Clin Infect Dis; 2008 Jul; 47(1):73-82. PubMed ID: 18484878
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic aspects of cerebrospinal fluid penetration of fosfomycin.
Pfeifer G; Frenkel C; Entzian W
Int J Clin Pharmacol Res; 1985; 5(3):171-4. PubMed ID: 4018950
[TBL] [Abstract][Full Text] [Related]
4. Do antibiotic-impregnated shunts in hydrocephalus therapy reduce the risk of infection? An observational study in 258 patients.
Ritz R; Roser F; Morgalla M; Dietz K; Tatagiba M; Will BE
BMC Infect Dis; 2007 May; 7():38. PubMed ID: 17488498
[TBL] [Abstract][Full Text] [Related]
5. Reduction in shunt infection using antibiotic impregnated CSF shunt catheters: an Australian prospective study.
Pattavilakom A; Xenos C; Bradfield O; Danks RA
J Clin Neurosci; 2007 Jun; 14(6):526-31. PubMed ID: 17430776
[TBL] [Abstract][Full Text] [Related]
6. Pediatric neurosurgical practice patterns designed to prevent cerebrospinal fluid shunt infection.
Gruber TJ; Riemer S; Rozzelle CJ
Pediatr Neurosurg; 2009; 45(6):456-60. PubMed ID: 20110759
[TBL] [Abstract][Full Text] [Related]
7. Conservative management of patients with cerebrospinal fluid shunt infections.
Brown EM; Edwards RJ; Pople IK
Neurosurgery; 2006 Apr; 58(4):657-65; discussion 657-65. PubMed ID: 16575329
[TBL] [Abstract][Full Text] [Related]
8. Management of complicated shunt infections: a clinical report.
James HE; Bradley JS
J Neurosurg Pediatr; 2008 Mar; 1(3):223-8. PubMed ID: 18352767
[TBL] [Abstract][Full Text] [Related]
9. Speciation analysis of selected metals and determination of their total contents in paired serum and cerebrospinal fluid samples: An approach to investigate the permeability of the human blood-cerebrospinal fluid-barrier.
Nischwitz V; Berthele A; Michalke B
Anal Chim Acta; 2008 Oct; 627(2):258-69. PubMed ID: 18809082
[TBL] [Abstract][Full Text] [Related]
10. [Penetration of ceftriaxone into the cerebrospinal fluid and its relationship to inflammatory markers during bacterial meningitis].
Prásil P; Buchta V; Paterová P; Hanovcová I
Klin Mikrobiol Infekc Lek; 2010 Apr; 16(2):64-72. PubMed ID: 20503158
[TBL] [Abstract][Full Text] [Related]
11. Aggressive management of shunt infection: combined intravenous and intraventricular antibiotic therapy for twelve or less days.
James HE; Bradley JS
Pediatr Neurosurg; 2008; 44(2):104-11. PubMed ID: 18230923
[TBL] [Abstract][Full Text] [Related]
12. Blood-brain barrier penetration of cefepime after neurosurgery.
Wang JF; Wang Q; Zhao LH; Shi GZ; Zhou JX
Chin Med J (Engl); 2007 Jul; 120(13):1176-8. PubMed ID: 17637248
[TBL] [Abstract][Full Text] [Related]
13. Antibiotic prophylaxis in cerebrospinal fluid shunting: a prospective randomized trial in 129 patients.
Zentner J; Gilsbach J; Felder T
Neurosurg Rev; 1995; 18(3):169-72. PubMed ID: 8570063
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and CSF penetration of moxalactam in antibiotic prophylaxis in neurosurgery.
Sachsenheimer W; Kühner A; Fabricius K
Neurochirurgia (Stuttg); 1985 Sep; 28(5):188-9. PubMed ID: 4058633
[TBL] [Abstract][Full Text] [Related]
15. [Prophylactic administration of an antibiotic in neurosurgical operations--penetration of cefotiam into the cerebrospinal fluid].
Imagawa K; Nomura T; Asai A; Hayashi M; Toda I; Kawasaki M
Jpn J Antibiot; 1983 Dec; 36(12):3422-8. PubMed ID: 6325752
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of ampicillin, sulbactam and cefotiam in patients undergoing orthopedic surgery.
Wildfeuer A; Mallwitz J; Gotthardt H; Hille E; Gruber H; Dahmen G; Pfaff G; Göbel C
Infection; 1997; 25(4):258-62. PubMed ID: 9266270
[TBL] [Abstract][Full Text] [Related]
17. Antibiotic prophylaxis for cerebrospinal fluid shunts: a metanalysis.
Haines SJ; Walters BC
Neurosurgery; 1994 Jan; 34(1):87-92. PubMed ID: 8121573
[TBL] [Abstract][Full Text] [Related]
18. Vancomycin versus cefazolin prophylaxis for cerebrospinal shunt placement in a hospital with a high prevalence of meticillin-resistant Staphylococcus aureus.
Tacconelli E; Cataldo MA; Albanese A; Tumbarello M; Arduini E; Spanu T; Fadda G; Anile C; Maira G; Federico G; Cauda R
J Hosp Infect; 2008 Aug; 69(4):337-44. PubMed ID: 18602187
[TBL] [Abstract][Full Text] [Related]
19. The Role of Antibiotic Prophylaxis in Shunt Surgery.
Li G; Pu K; Cao Y; Wang J; Sun Z; Li Q
World Neurosurg; 2017 Dec; 108():548-554. PubMed ID: 28838878
[TBL] [Abstract][Full Text] [Related]
20. Clinical and economic consequences of antibiotic-impregnated cerebrospinal fluid shunt catheters.
Eymann R; Chehab S; Strowitzki M; Steudel WI; Kiefer M
J Neurosurg Pediatr; 2008 Jun; 1(6):444-50. PubMed ID: 18518694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
